Baby Safety / Compounds / Monensin

Is Monensin safe for babies and kids?

Very high risk for kids

Infants are more vulnerable to Monensin than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is monensin?

CAS number
17090-79-8
Molecular formula
C36H62O11
Molecular weight
670.87 g/mol
SMILES
CCC1C(CC2(CC(C(C(O2)CC(C(C3C(CC(O3)C(CC4CC(OC4CC(C1O)C)O)C)C)O)C)O)O)C)C
PubChem CID
441145

Risk for babies

Very high risk

Infants are more vulnerable to Monensin than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Monensin, potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

1 regulatory bodyhas classified Monensin.

AgencyYearClassificationNotes
FDA1975Approved veterinary feed additive (NADA 095-735)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter monensin

  • Veterinary Medicine

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Monensin:

  • Decoquinate (non-ionophore)
    Trade-offs: Alternative approach; specific tradeoffs depend on application context, scale, and regulatory requirements. Full hazard assessment of alternative recommended before adoption to avoid regrettable substitution.
    Relative cost: 1.2-2×

Frequently asked questions

Is monensin safe for kids?

Infants are more vulnerable to Monensin than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What should I do if my child is exposed to monensin?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

See Monensin in the baby app

Look up products containing monensin, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. —

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →